Skip to content
Search

Latest Stories

Search Results for nhs

Support for generic medicines manufacturers key to affordable healthcare- Teva UK director
Features

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

Support for generic medicine manufacturers key to affordable healthcare, says Teva UK director Ryan Ruscoe.

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer
News

NICE approves twice-a-day tablet for advanced breast cancer

Recommended for people with hormone receptor (HR)-positive HER2-negative breast cancer, the treatment may delay the need for chemotherapy and its associated side-effects

Community pharmacies should stop offering services for free
News

“Stop doing things for free”- Pharmacy leaders urge contractors

Pharmacy Business Conference 2025
News

Pharmacy Business Conference 2025: Pharmacy leaders urge sector to embrace innovation as funding gaps persist

Start thinking about how to react to pay review- PD tells NHS pharmacists

PDA urges NHS pharmacists to prepare response as government delays pay reviews

All NHS pharmacists are encouraged to stay informed about current inflation rates and forecasts to help them decide a fair pay increase.

Janet Morrison discusses pharmacy funding strategy at 2025 conference
Features

CPE calls new funding deal a ‘reluctant yes’

The government has committed to working with the organisation to establish “a sustainable funding and operating model” for the future, according to CPE chief executive Janet Morrison.

New pharmacy contract marks a vital step forward for the sector - Wes Streeting
News

Wes Streeting: New pharmacy contract demonstrates our commitment to rebuilding the sector

Streeting has pledged to deliver the fundamental reforms needed to revitalise the sector through the government’s plan for change.

ABPI and government fast-track VPAG scheme review to address high medicine payment rates
News

Review of 2024 VPAG scheme to be completed by June

The review will focus on addressing concerns about the high ‘headline payment rate’ for newer medicines in the VPAG scheme.

© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc